Phase Ⅲ Trial of Group ACYW135 Meningococcal Conjugate Vaccine in Children Aged 12-23 Months
Phase Ⅲ Trial of Group ACYW135 Meningococcal Conjugate Vaccine in Children Aged 12-23 Months
Recruiting · NCT07505836 · Registry updated 2026-08-10Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase Ⅲ Trial of Group ACYW135 Meningococcal Conjugate Vaccine in Children Aged 12-23 Months | Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, Infections, Neisseriaceae Infections, Neuroinflammatory Diseases, bacterial infectious disease, bacterial meningitis, central nervous system disorder, central nervous system infectious disorder, gram-negative bacterial infections, meningitis, meningococcal infection, meningococcal meningitis, nervous system disorder | Recruiting | Phase 3 | 2026-08-10 | NCT07505836 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Sinovac Biotech Co., Ltd | 19 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Guangxi Zhuang Autonomous Region Center for Disease Control and Prevention | Nanning | China | 7 |
| Shanxi Provincial Center for Disease Control and Prevention | Taiyuan | China | 3 |